Lung Cancer Pioneer Dr. Gilberto Lopes Joins Longevity Company Immorta Bio

Company collaborating with FDA to advance senolytic immunotherapy (SenoVax™) into clinical trials for NSCLC MIAMI, Sept. 17, 2025 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity company dedicated to "Treating Diseases of Aging and Treating Aging as Disease™," today announced the...